Dib, L. et al. Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis increasing the risk of cerebrovascular complications. Nat. Cardiovasc. Res. 2, 656–672 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576–1588 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Porsch, F. & Binder, C. J. Autoimmune diseases and atherosclerotic cardiovascular disease. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-024-01045-7 (2024).

Maffia, P., Mauro, C., Case, A. & Kemper, C. Canonical and non-canonical roles of complement in atherosclerosis. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-024-01016-y (2024).

Döring, Y., van der Vorst, E. P. C. & Weber, C. Targeting immune cell recruitment in atherosclerosis. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-024-01023-z (2024).

Adkar, S. S. & Leeper, N. J. Efferocytosis in atherosclerosis. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-024-01037-7 (2024).

Fredman, G. & Serhan, C. N. Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-023-00984-x (2024).

Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med 377, 1119–1131 (2017).

Article  CAS  PubMed  Google Scholar 

Tsiantoulas, D. et al. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans. Nature 597, 92–96 (2021).

Article  CAS  PubMed  Google Scholar 

Lutgens, E. et al. Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5, 1313–1316 (1999).

Article  CAS  PubMed  Google Scholar 

Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178–180 (2006).

Article  CAS  PubMed  Google Scholar 

Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab 33, 2445–2463.e8 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, I. et al. C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and protects against atherosclerosis. Nat. Commun. 13, 215 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar